Literature DB >> 16828131

Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001: regional analyses using the general practice research database.

S Smith1, G E Smith, H Heatlie, J N R Bashford, D M Ashcroft, N Q Verlander, G J Duckworth, B Mason, B Smyth, S Maxwell.   

Abstract

OBJECTIVE: To use the General Practice Research Database (GPRD) to explore the regional variation in prescribing for single diagnostic episodes of 'cough/cold' and sore throat and how this changed between 1993 and 2001.
METHODS: Data from the GPRD was used to conduct a longitudinal survey of morbidity and antibiotic prescribing data.
RESULTS: Nationally there has been a substantial reduction in diagnosed episodes per 1000 patient years at risk for both diagnoses: from 104.6 (104.0-105.2) to 86.5 (86.0-86.9) for cough/cold (-17.3%) and from 102.8 (102.2-103.4) to 69.2 (68.8-69.6) for sore throat (-32.6%). In addition to the changes in diagnostic rate there have been reductions in diagnosis-related prescribing: from 41.8% to 34.8% of cough/cold episodes (-7.0%) and from 77.3% to 60.8% of sore throat episodes (-16.4%). These aggregated data conceal wide regional variations. For cough/cold the change in prescribing rate during the study varied from -16.0% to +5.3% and for sore throat from -28.3% to -7.3%.
CONCLUSIONS: In addition to a substantial reduction in diagnosis of cough/cold and sore throat, there has been a reduction in diagnosis-related prescribing episodes in almost all regions. Although there continues to be regional variation in diagnosis-related prescribing this has reduced substantially over the 9-year study period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828131     DOI: 10.1016/j.puhe.2006.02.007

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  8 in total

1.  Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.

Authors:  Hannah Fraser; Daniel Gallacher; Felix Achana; Rachel Court; Sian Taylor-Phillips; Chidozie Nduka; Chris Stinton; Rebecca Willans; Paramjit Gill; Hema Mistry
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

2.  Variation in outpatient antibiotic prescribing in the United States.

Authors:  Michael A Steinman; Katherine Y Yang; Sepheen C Byron; Judith H Maselli; Ralph Gonzales
Journal:  Am J Manag Care       Date:  2009-12       Impact factor: 2.229

Review 3.  A review of geographic variation and Geographic Information Systems (GIS) applications in prescription drug use research.

Authors:  Victoria Wangia; Theresa I Shireman
Journal:  Res Social Adm Pharm       Date:  2013-01-18

4.  Which practices are high antibiotic prescribers? A cross-sectional analysis.

Authors:  Kay Yee Wang; Paul Seed; Peter Schofield; Saima Ibrahim; Mark Ashworth
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

5.  Reduced antibiotic prescribing for acute respiratory infections in adults and children.

Authors:  Sharon B Meropol; Zhen Chen; Joshua P Metlay
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

6.  Skin infections and antibiotic prescribing: a comparison of surveillance and prescribing data.

Authors:  Douglas M Fleming; Alex J Elliot; Helen Kendall
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

7.  An intervention modelling experiment to change GPs' intentions to implement evidence-based practice: using theory-based interventions to promote GP management of upper respiratory tract infection without prescribing antibiotics #2.

Authors:  Susan Hrisos; Martin Eccles; Marie Johnston; Jill Francis; Eileen F S Kaner; Nick Steen; Jeremy Grimshaw
Journal:  BMC Health Serv Res       Date:  2008-01-14       Impact factor: 2.655

8.  A standardized methodology for the surveillance of antimicrobial prescribing linked to clinical indications in primary care.

Authors:  Sue Smith; Jeremy I Hawker; Gillian E Smith; Roger Morbey; Alan P Johnson; Douglas M Fleming; Laura Shallcross; Andrew C Hayward
Journal:  J Public Health (Oxf)       Date:  2018-09-01       Impact factor: 2.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.